XEC, which was first identified in Germany in June, has now been spotted in Denmark, France, the Netherlands, the U.K., Canada and the U.S., according to lineage tracking graphs shared by data ...
Human papillomavirus (virus like particle, 9-valent) vaccine is under clinical development by Merck and currently in Phase II for Human Papillomavirus Infections.
GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...